Aurinia Pharmaceuticals Inc. 8-K

What Happened
Aurinia Pharmaceuticals Inc. filed an 8-K on June 4, 2026 reporting the results of its virtual annual general meeting of shareholders held June 3, 2026. Shareholders elected five director nominees to serve until the 2027 annual meeting, approved the appointment of PricewaterhouseCoopers LLP as the company’s independent registered public accounting firm for 2026–2027, and passed a non‑binding “say on pay” advisory vote on executive compensation.

Key Details

• Directors elected (terms until the 2027 AGM):
  • Kevin Tang — For: 68,889,411; Withheld: 2,434,090; For % (of votes cast): 96.59%
  • Jeffrey Bailey — For: 67,990,723; Withheld: 3,332,778; For %: 95.33%
  • Kathy Goetz — For: 68,840,807; Withheld: 2,482,694; For %: 96.52%
  • Craig Johnson — For: 61,694,786; Withheld: 9,628,715; For %: 86.50%
  • Tina S. Nova — For: 61,972,942; Withheld: 9,350,560; For %: 86.89%
  • Note: Broker non‑votes were reported for the director elections (16,049,984).
• Auditor appointment: PricewaterhouseCoopers LLP approved as independent registered public accounting firm for the year ending with the 2027 AGM (For: 77,785,132; Withhold: 9,488,350).
• Say-on-pay (non‑binding advisory): Approved by shareholders (For: 66,398,971 or 93.10% of votes cast; Against: 4,315,143 or 6.05%; Abstain: 609,384). Broker non‑votes reported (16,049,987).

Why It Matters

• Board continuity and governance: The election of all five nominees maintains the board’s composition through 2027; two nominees (Craig Johnson and Tina Nova) received noticeably lower support (~86.5–86.9%) versus the other directors (~95–96%), which investors may watch for future governance or engagement signals.
• Auditor confirmation: Re‑appointment of PwC provides continuity for the company’s external audit process and financial reporting oversight.
• Executive compensation: Strong voter support (93.1%) on the advisory say‑on‑pay indicates broad shareholder approval of the company’s executive pay policies as presented at the meeting.

Filed by Aurinia on June 4, 2026; report signed by Stephen P. Robertson, Chief Legal Officer, Corporate Secretary and Chief Compliance Officer.